APO RESEARCH · REPORT
Specialty Drug Distribution
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
Product & engineering
Understand the product.
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Selected research
Industry Research
Specialty Drug Distribution Industry Research Report 2026
Market perspective
Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Read the full market overview
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.
Report Scope
This report quantifies the global Specialty Drug Distribution market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Specialty Drug Distribution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Specialty Drug Distribution Market by Company
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma
Specialty Drug Distribution Segment by Type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Specialty Drug Distribution Segment by Application
Hospital and Clinic
Pharmacy
Others
Specialty Drug Distribution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Drug Distribution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Specialty Drug Distribution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Drug Distribution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Specialty Drug Distribution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oncology
- Rheumatoid Arthritis
- Multiple Sclerosis
- Hemophilia
- Others
Applications
- Hospital and Clinic
- Pharmacy
- Others
Companies covered
- AmerisourceBergen
- Mckesson
- Cardinal Health
- Phoenix
- Medipal Holdings
- Alliance Healthcare
- Sinopharm
- Express Scripts
- Shanghai Pharma
- Anda
- Jointown
- Max Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Specialty Drug Distribution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oncology
- 2.2.3 Rheumatoid Arthritis
- 2.2.4 Multiple Sclerosis
- 2.2.5 Hemophilia
- 2.2.6 Others
- 2.3 Specialty Drug Distribution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital and Clinic
- 2.3.3 Pharmacy
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Specialty Drug Distribution Breakdown Data by Type
- 3.1 Global Specialty Drug Distribution Historic Market Size by Type (2021-2026)
- 3.2 Global Specialty Drug Distribution Forecasted Market Size by Type (2027-2032)
4 Specialty Drug Distribution Breakdown Data by Application
- 4.1 Global Specialty Drug Distribution Historic Market Size by Application (2021-2026)
- 4.2 Global Specialty Drug Distribution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Specialty Drug Distribution Market Perspective (2021-2032)
- 5.2 Global Specialty Drug Distribution Growth Trends by Region
- 5.2.1 Global Specialty Drug Distribution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Specialty Drug Distribution Historic Market Size by Region (2021-2026)
- 5.2.3 Specialty Drug Distribution Forecasted Market Size by Region (2027-2032)
- 5.3 Specialty Drug Distribution Market Dynamics
- 5.3.1 Specialty Drug Distribution Industry Trends
- 5.3.2 Specialty Drug Distribution Market Drivers
- 5.3.3 Specialty Drug Distribution Market Challenges
- 5.3.4 Specialty Drug Distribution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Specialty Drug Distribution Players by Revenue
- 6.1.1 Global Top Specialty Drug Distribution Players by Revenue (2021-2026)
- 6.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2021-2026)
- 6.2 Global Specialty Drug Distribution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Specialty Drug Distribution Head Office and Area Served
- 6.4 Global Specialty Drug Distribution Players, Product Type & Application
- 6.5 Global Specialty Drug Distribution Manufacturers Established Date
- 6.6 Global Specialty Drug Distribution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Specialty Drug Distribution Market Size (2021-2032)
- 7.2 North America Specialty Drug Distribution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Specialty Drug Distribution Market Size by Country (2021-2026)
- 7.4 North America Specialty Drug Distribution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Specialty Drug Distribution Market Size (2021-2032)
- 8.2 Europe Specialty Drug Distribution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Specialty Drug Distribution Market Size by Country (2021-2026)
- 8.4 Europe Specialty Drug Distribution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Specialty Drug Distribution Market Size (2021-2032)
- 9.2 Asia-Pacific Specialty Drug Distribution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Specialty Drug Distribution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Specialty Drug Distribution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Specialty Drug Distribution Market Size (2021-2032)
- 10.2 South America Specialty Drug Distribution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Specialty Drug Distribution Market Size by Country (2021-2026)
- 10.4 South America Specialty Drug Distribution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Specialty Drug Distribution Market Size (2021-2032)
- 11.2 Middle East & Africa Specialty Drug Distribution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Specialty Drug Distribution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Specialty Drug Distribution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AmerisourceBergen
- 12.1.1 AmerisourceBergen Company Information
- 12.1.2 AmerisourceBergen Business Overview
- 12.1.3 AmerisourceBergen Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.1.4 AmerisourceBergen Specialty Drug Distribution Product Portfolio
- 12.1.5 AmerisourceBergen Recent Developments
- 12.2 Mckesson
- 12.2.1 Mckesson Company Information
- 12.2.2 Mckesson Business Overview
- 12.2.3 Mckesson Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.2.4 Mckesson Specialty Drug Distribution Product Portfolio
- 12.2.5 Mckesson Recent Developments
- 12.3 Cardinal Health
- 12.3.1 Cardinal Health Company Information
- 12.3.2 Cardinal Health Business Overview
- 12.3.3 Cardinal Health Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.3.4 Cardinal Health Specialty Drug Distribution Product Portfolio
- 12.3.5 Cardinal Health Recent Developments
- 12.4 Phoenix
- 12.4.1 Phoenix Company Information
- 12.4.2 Phoenix Business Overview
- 12.4.3 Phoenix Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.4.4 Phoenix Specialty Drug Distribution Product Portfolio
- 12.4.5 Phoenix Recent Developments
- 12.5 Medipal Holdings
- 12.5.1 Medipal Holdings Company Information
- 12.5.2 Medipal Holdings Business Overview
- 12.5.3 Medipal Holdings Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.5.4 Medipal Holdings Specialty Drug Distribution Product Portfolio
- 12.5.5 Medipal Holdings Recent Developments
- 12.6 Alliance Healthcare
- 12.6.1 Alliance Healthcare Company Information
- 12.6.2 Alliance Healthcare Business Overview
- 12.6.3 Alliance Healthcare Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.6.4 Alliance Healthcare Specialty Drug Distribution Product Portfolio
- 12.6.5 Alliance Healthcare Recent Developments
- 12.7 Sinopharm
- 12.7.1 Sinopharm Company Information
- 12.7.2 Sinopharm Business Overview
- 12.7.3 Sinopharm Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.7.4 Sinopharm Specialty Drug Distribution Product Portfolio
- 12.7.5 Sinopharm Recent Developments
- 12.8 Express Scripts
- 12.8.1 Express Scripts Company Information
- 12.8.2 Express Scripts Business Overview
- 12.8.3 Express Scripts Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.8.4 Express Scripts Specialty Drug Distribution Product Portfolio
- 12.8.5 Express Scripts Recent Developments
- 12.9 Shanghai Pharma
- 12.9.1 Shanghai Pharma Company Information
- 12.9.2 Shanghai Pharma Business Overview
- 12.9.3 Shanghai Pharma Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.9.4 Shanghai Pharma Specialty Drug Distribution Product Portfolio
- 12.9.5 Shanghai Pharma Recent Developments
- 12.10 Anda
- 12.10.1 Anda Company Information
- 12.10.2 Anda Business Overview
- 12.10.3 Anda Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.10.4 Anda Specialty Drug Distribution Product Portfolio
- 12.10.5 Anda Recent Developments
- 12.11 Jointown
- 12.11.1 Jointown Company Information
- 12.11.2 Jointown Business Overview
- 12.11.3 Jointown Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.11.4 Jointown Specialty Drug Distribution Product Portfolio
- 12.11.5 Jointown Recent Developments
- 12.12 Max Pharma
- 12.12.1 Max Pharma Company Information
- 12.12.2 Max Pharma Business Overview
- 12.12.3 Max Pharma Revenue in Specialty Drug Distribution Business (2021-2026)
- 12.12.4 Max Pharma Specialty Drug Distribution Product Portfolio
- 12.12.5 Max Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst